메뉴 건너뛰기




Volumn 45, Issue 12, 2012, Pages 1334-1340

Clinicopathological significance of PTPN12 expression in human breast cancer

Author keywords

Breast cancer; Methylation; Prognosis; PTPN12; Tumor suppressor gene

Indexed keywords

MESSENGER RNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 12;

EID: 84872291149     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500163     Document Type: Article
Times cited : (17)

References (13)
  • 2
    • 33744960226 scopus 로고    scopus 로고
    • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
    • Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492-2502.
    • (2006) JAMA , vol.295 , pp. 2492-2502
    • Carey, L.A.1    Perou, C.M.2    Livasy, C.A.3    Dressler, L.G.4    Cowan, D.5    Conway, K.6
  • 3
  • 5
    • 34447529493 scopus 로고    scopus 로고
    • Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells
    • Sahu SN, Nunez S, Bai G, Gupta A. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells. Am J Physiol Cell Physiol 2007; 292: C2288-C2296.
    • (2007) Am J Physiol Cell Physiol , vol.292
    • Sahu, S.N.1    Nunez, S.2    Bai, G.3    Gupta, A.4
  • 6
    • 79952292499 scopus 로고    scopus 로고
    • Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase
    • Sun T, Aceto N, Meerbrey KL, Kessler JD, Zhou C, Migliaccio I, et al. Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. Cell 2011; 144: 703-718.
    • (2011) Cell , vol.144 , pp. 703-718
    • Sun, T.1    Aceto, N.2    Meerbrey, K.L.3    Kessler, J.D.4    Zhou, C.5    Migliaccio, I.6
  • 7
    • 0036274359 scopus 로고    scopus 로고
    • The fundamental role of epigenetic events in cancer
    • Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
    • (2002) Nat Rev Genet , vol.3 , pp. 415-428
    • Jones, P.A.1    Baylin, S.B.2
  • 8
    • 33847065486 scopus 로고    scopus 로고
    • The epigenomics of cancer
    • Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-692.
    • (2007) Cell , vol.128 , pp. 683-692
    • Jones, P.A.1    Baylin, S.B.2
  • 9
    • 0034895071 scopus 로고    scopus 로고
    • Over expression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype
    • Milde-Langosch K, Bamberger AM, Rieck G, Kelp B, Löning T. Over expression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res Treat 2001; 67: 61-70.
    • (2001) Breast Cancer Res Treat , vol.67 , pp. 61-70
    • Milde-Langosch, K.1    Bamberger, A.M.2    Rieck, G.3    Kelp, B.4    Löning, T.5
  • 10
    • 79960671119 scopus 로고    scopus 로고
    • Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assay
    • Chae BJ, Bae JS, Yim HW, Lee A, Song BJ, Jeon HM, et al. Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assay. Pathology 2011; 43: 248-253.
    • (2011) Pathology , vol.43 , pp. 248-253
    • Chae, B.J.1    Bae, J.S.2    Yim, H.W.3    Lee, A.4    Song, B.J.5    Jeon, H.M.6
  • 11
    • 33847147313 scopus 로고    scopus 로고
    • American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    • Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25: 118-145.
    • (2007) J Clin Oncol , vol.25 , pp. 118-145
    • Wolff, A.C.1    Hammond, M.E.2    Schwartz, J.N.3    Hagerty, K.L.4    Allred, D.C.5    Cote, R.J.6
  • 13
    • 36549029229 scopus 로고    scopus 로고
    • Correlation between CpG methylation profiles and hormone receptor status in breast cancers
    • Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, et al. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res 2007; 9: R57.
    • (2007) Breast Cancer Res , vol.9
    • Feng, W.1    Shen, L.2    Wen, S.3    Rosen, D.G.4    Jelinek, J.5    Hu, X.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.